Final Phase II Data Evaluating REVLIMID® and Rituximab in Patients with …Business Wire (press release)In the study, 59 patients received rituximab 375 mg/m 2 intravenously weekly for four weeks in cycle one, and then once every four weeks during cyc…
Xenotransplantation: using pigs as organ and tissue donors for humans – The Conversation
Xenotransplantation: using pigs as organ and tissue donors for humansThe ConversationThis is called xenotransplantation. Humans are primates, so the obvious choice of donor animal for xenotransplantation would appear to be another member of the primate…
State Official Promotes Importance of Organ Donation – NJ TODAY
State Official Promotes Importance of Organ DonationNJ TODAYOrgan donor registration is available online or in-person at your local Motor Vehicle Commission agency. For more details, visit www.state.nj.us/mvc/Licenses/organ_donor.htm “Once you regist…
Midlands teen leaves his legacy through organ donation – WACH
WLTX.comMidlands teen leaves his legacy through organ donationWACHKatie McKee joined the WACH Fox News team in October of 2011. She is a new addition to the cast of Good Day Columbia and works weekends as a Multi-Media Journalist. Jesse Miller Gamble&#…
Early PET Predicts Survival Outcomes in B-Cell Lymphoma – MD News (press release)
MD News (press release)Early PET Predicts Survival Outcomes in B-Cell LymphomaMD News (press release)An interim [ 18 F] fluorodeoxyglucose positron emission tomography can effectively predict the survival outcomes of patients with diffuse large B-cell …
Early PET Predicts Survival Outcomes in B-Cell Lymphoma – Doctors Lounge
MD NewsEarly PET Predicts Survival Outcomes in B-Cell LymphomaDoctors LoungeAn interim [ 18 F] fluorodeoxyglucose positron emission tomography can effectively predict the survival outcomes of patients with diffuse large B-cell lymphoma after two cycles…
REVLIMID(R) Evaluated in Combination with Rituximab as a Potential Treatment … – MarketWatch (press release)
REVLIMID(R) Evaluated in Combination with Rituximab as a Potential Treatment …MarketWatch (press release)The multicenter phase II study enrolled 69 patients and evaluated the efficacy and safety of combination therapy with lenalidomide and rituximab …
Major cause of chronic kidney disease-related inflammation is identified – HealthCanal.com
AsiaOneMajor cause of chronic kidney disease-related inflammation is identifiedHealthCanal.comUC Irvine researchers have uncovered an important source of inflammation seen in people with chronic kidney disease, which is increasingly common due to the e…
Organ donor Alison gave the gift of life to others – Enniscorthy Guardian
Organ donor Alison gave the gift of life to othersEnniscorthy GuardianTHE tragic death of a woman after she fell down stairs gave the gift of life to several others as she was an organ donor, Wexford Coroner's Court has heard. The inquest into the …
ASH: Obinutuzumab Bests Rituximab in Patients With Relapsed Non-Hodgkin Lymphoma – Cancer Network
ASH: Obinutuzumab Bests Rituximab in Patients With Relapsed Non-Hodgkin LymphomaCancer NetworkSAN DIEGO—Obinutuzumab (GA101) achieved higher response rates than rituximab in the first head-to-head trial of the two biologic agents in patients with rel…